جست‌وجوی استاد و پژوهشگر

Nina Frederike Jeppesen Edinمشاهده پروفایل

استاد

• Radiation biology
• Hypoxia effects on radiation resistance
• Proton therapy mechanisms
• +۷ مورد دیگر

Nina Frederike Jeppesen Edin is a Professor in the Department of Biophysics and Medical Physics at the University of Oslo, specializing in cellular radiation effects and hypoxia research. Her work bridges medical physics and radiobiology with clinical applications in cancer therapy. Her primary research interests focus on: Cellular effects of radiation and hypoxia TGF-beta3 signaling in radiation response Proton therapy mechanisms and delivery optimization Low dose-rate radiation effects Radiation-induced immunogenic cell death Late effects of radiotherapy Her laboratory investigates fundamental radiobiological mechanisms while developing clinical applications, particularly in head and neck cancer treatment. Analysis of her 15 most recent publications (2023-2025) reveals strong emphasis on proton therapy comparisons with conventional radiation, salivary gland complications, cytokine-mediated radiation responses, and advanced dosimetry techniques. Her work consistently employs murine models and molecular profiling to understand radiation quality effects. Professor Edin teaches key courses including FYS2150 Experimental Physics, FYS4720/9720 Cellular Radiobiology, and FYS3820 Work Practice, training the next generation of medical physicists and radiobiologists. Her research is conducted within the Biophysics and Medical Physics group at the University of Oslo, utilizing advanced radiation facilities including the Oslo Cyclotron Laboratory referenced in her collaborative publications.

• Radiation Therapy
• Medical Imaging
• Cancer Treatment
• +۵ مورد دیگر

Dr. Elizabeth Brown is an Associate Professor in the School of Clinical Sciences within the Faculty of Health at Queensland University of Technology. With a research focus on radiation therapy and medical imaging, her work spans stereotactic body radiation therapy, image-guided radiation therapy, and specialized techniques for breast and head and neck cancers. She completed her PhD by Publication in 2016 with the thesis 'Biologically guided adaptive radiotherapy treatment planning for virally-mediated head and neck cancer' at QUT. Dr. Brown's research interests center on optimizing radiation therapy delivery through advanced imaging techniques and motion management strategies. Her work particularly focuses on stereotactic body radiation therapy (SBRT), deep inspiration breath hold (DIBH) techniques for breast cancer patients, and managing intrafraction motion in liver treatments. She has made significant contributions to understanding treatment time efficiency, dosimetric comparisons between different radiation techniques, and the physiological effects of radiotherapy on swallowing mechanisms in head and neck cancer patients. Analysis of her recent publications reveals a strong emphasis on clinical implementation of advanced radiotherapy techniques, with particular attention to patient-specific factors that influence treatment outcomes. Her research bridges the gap between technical radiation delivery and patient care considerations, often examining how technical parameters translate to clinical outcomes and patient experience. Dr. Brown actively collaborates with interdisciplinary teams including radiation oncologists, medical physicists, radiation therapists, and other healthcare professionals. Her work demonstrates a commitment to improving both the technical precision of radiation therapy and the holistic care of cancer patients throughout their treatment journey.

Fei Zhaoمشاهده پروفایل

استادیار

• Reproductive Biology
• Sexual Differentiation
• Developmental Biology
• +۴ مورد دیگر

Fei Zhao is an Assistant Professor in the Department of Comparative Biosciences at the University of Wisconsin-Madison's School of Veterinary Medicine. He joined the university in 2020 after completing his postdoctoral training at the National Institute of Environmental Health Sciences. His research focuses on understanding the cellular and molecular mechanisms underlying sexual differentiation of reproductive tracts. Dr. Zhao's research interests center on reproductive biology, sexual differentiation, and developmental biology. His laboratory investigates how sex hormones regulate reproductive tract development and how environmental chemicals that mimic sex hormones can disrupt normal differentiation processes. His work combines molecular biology, genetics, and developmental approaches to understand fundamental mechanisms of reproductive tract formation. His recent publications demonstrate a strong focus on Wolffian and Müllerian duct development, with an emphasis on mesenchymal-epithelial interactions, androgen signaling, and patterning mechanisms. His research employs transgenic and conditional knockout mouse models, ex vivo organ culture techniques, and genomic approaches. Dr. Zhao currently mentors PhD student McKenna Crossen, who previously completed her MS under his supervision. His research has important implications for understanding disorders of sex development and reproductive diseases.

Nicholas B. Remmesمشاهده پروفایل

پژوهشگر

• Medical Physics
• Radiation Oncology
• Proton Therapy
• +۴ مورد دیگر

Nicholas B. Remmes, Ph.D. , is a Radiation Oncology Medical Physicist at Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota. He holds a Therapeutic Medical Physics Certification (2012) Doctoral degree in Physics from Indiana University (2007) Master's and Bachelor's in Physics and Mathematics His research focuses on Heavy ion radiobiological modeling Monte Carlo simulations for therapeutic beams Proton therapy shielding validation Dose optimization for cancer treatments Neutron fluence measurement with recent studies spanning 2025 publications on mouse oral cavity toxicity, breast cancer outcomes, and radiation QA phantoms. Scientific recognition includes 2024 Teacher of the Year – Radiation Physics 2016 Guilford College Distinguished Alumni Award 2006 & 2005 Indiana University Awards 2002 GAANN Fellowship 1996 AAPT Connolly Award He actively contributes to JED&I Committee (2022–present) Medical Physics Education (2017–present) SDAMPP Membership (2015–present) Neutron source development (2007) and has co-authored 15+ clinical and preclinical radiation studies since 2011.

• Pediatric Neuroradiology
• Oncologic Imaging
• Quantitative MRI
• +۲ مورد دیگر

Benita Tamrazi is an Associate Professor of Radiology (Clinical Scholar) specializing in pediatric neuroradiology and oncologic imaging. Her research encompasses advanced neuroimaging techniques, quantitative MRI biomarkers, and imaging protocol standardization for pediatric CNS disorders. Key research areas include: imaging biomarkers for hypoxic-ischemic encephalopathy in neonates; AI-based tumor segmentation in medulloblastoma; CSF flow dynamics in shunted hydrocephalus; and neuroimaging complications of immunotherapies. Recent work establishes standardized response assessment protocols for pediatric brain tumors through RAPNO working groups. Publication themes show focus on pediatric neuro-oncology (64%), particularly medulloblastoma (21%) and pineal tumors (7%). Technical innovations include AI segmentation (7%), quantitative CSF flow (11%), and metabolic imaging (7%). Clinical applications span treatment monitoring (21%), complication detection (14%), and guideline development (14%).

Yuxiang Wangمشاهده پروفایل

دانشیار

• Fish Physiology
• Aquaculture
• Ecotoxicology
• +۵ مورد دیگر

Yuxiang Wang is an Associate Professor in the Department of Biology at Queen's University, cross-appointed to the School of Environmental Studies and the Beaty Water Research Centre within the Faculty of Arts and Science. He holds a Ph.D. in Animal Physiology and Toxicology from McMaster University (1996), an M.Sc. in Aquatic Toxicology from Trent University (1990), and a B.Sc.H. in Biology from Beijing Normal University (1984). His research focuses on understanding metabolic mechanisms in fish, particularly how they adapt to environmental stressors. Key areas include ecotoxicology (e.g., fish responses to anthropogenic stressors), aquaculture optimization (e.g., enhancing growth conditions for aquatic organisms), and mitigating harmful algal blooms using UAVs and eDNA technologies. He co-leads an NFRF Innovation grant developing metabarcoding tools for aquatic biodiversity monitoring. He also teaches a China-Canada field course on human impacts in aquatic environments since 2005. Research Highlights: Metabolic balance in fish under varying physiological states. Adaptations of Lake Qinghai's scale-less carp to high-altitude saline environments. Genetic and molecular mechanisms influencing chicken fat deposition and lipid metabolism. Labs and Affiliations: Yuxiang Wang Lab (specializing in aquatic physiology and ecotoxicology). Beaty Water Research Centre collaborations on freshwater ecosystems.

Nanna Maria Sijtsemaمشاهده پروفایل

پژوهشگر

• Radiotherapy
• Adaptive Radiotherapy (ART)
• Image Biomarkers
• +۷ مورد دیگر

Nanna Maria Sijtsema is a researcher specializing in radiotherapy and oncological imaging. Her work focuses on adaptive radiotherapy techniques, image biomarkers, and radiomics applications in cancer treatment. She has contributed to studies on head and neck cancer, proton therapy optimization, and normal tissue complication probability (NTCP) modeling. Sijtsema holds an editorial role at the journal Physica Medica . Her research interests include improving treatment outcomes through precision radiation oncology, integrating AI-driven imaging solutions, and predicting treatment-related side effects. Key collaborations involve international cohorts in head and neck cancer studies and proton therapy validation. Notable contributions include developing MRI-based tumor segmentation algorithms and evaluating PET/CT biomarkers for outcome prediction. She received recognition as a 2020 Best of ASTRO abstract recipient for collaborative work on radiation dose optimization in breast cancer patients.

• Bioinformatics
• Transcriptomics
• Gene Expression Analysis
• +۴ مورد دیگر

David Philip Kreil is an Associate Professor at the Institute of Molecular Biotechnology within the Department of Biotechnology and Food Science at the University of Natural Resources and Life Sciences, Vienna (BOKU) . He holds a joint appointment as Chair of Bioinformatics at the University of Warwick (2012-2014) and has held research positions at the European Bioinformatics Institute (EBI) and the University of Cambridge . His work bridges computational biology, transcriptomics, and plant-nematode interactions. 2012-2014: Chair of Bioinformatics, University of Warwick 2005: WWTF Vienna Science Chair at BOKU 2001-2004: MRC Research Fellow, University of Cambridge 1997-2001: EMBL PhD Programme, EBI Kreil's research focuses on transcriptomic analysis of plant-pathogen interactions (e.g., Fusarium resistance in wheat, nematode-induced syncytia) and computational methods for microarray calibration, data normalization, and statistical modeling. He has applied machine learning to weather forecasting and biomedical data. Scientific Awards : Research Fellow, Darwin College, University of Cambridge (2002-2005) His 15 most recent articles emphasize bioinformatics tools, plant immunity, and interdisciplinary applications of machine learning in biology and climate science. He has supervised theses on wheat transcriptomics and nematode-induced gene expression.

Nukhet Aykin-Burnsمشاهده پروفایل

دانشیار

• Reactive Oxygen Species (ROS)
• Mitochondrial Function
• Radiation-Induced Normal Tissue Damage
• +۴ مورد دیگر

Nukhet Aykin-Burns is an Associate Professor of Pharmaceutical Sciences at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy, with a secondary appointment in the Human Toxicology Program at The University of Iowa. Her research focuses on reactive oxygen species (ROS), mitochondrial function, and mechanisms of radiation-induced (IR/UV) normal tissue damage, wound healing, and polychlorinated biphenyl (PCB)-induced oxidative stress. She also leads efforts to develop radioprotectors and radiomitigators for Acute Radiation Syndromes (ARS). Recent publications highlight her work in radiation biology, oxidative stress, mitochondrial dysfunction, and toxicant-induced metabolic alterations. Themes include epigenetic regulation of immune cells, antioxidant therapies in radiation injury, and the interplay between environmental toxicants and cellular metabolism. Her laboratory investigates the molecular underpinnings of radiation and toxicant exposure, with a particular emphasis on mitochondrial-targeted interventions and translational applications for human health.

Marjan Boermaمشاهده پروفایل

استاد

• Radiation Biology
• Cardiovascular Research
• Radiation Toxicology
• +۳ مورد دیگر

Marjan Boerma is a Professor of Pharmaceutical Sciences and Director of the Division of Radiation Health at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy. Education: PhD in Radiation Biology, Leiden University (2004) Postdoctoral Fellowship, UAMS Research Focus: Specializes in studying normal tissue injury from ionizing radiation, particularly cardiovascular system damage. Her work addresses radiation therapy side effects, radiological accident consequences, and deep-space travel radiation risks using animal models. Research Trends: Focuses on radiation-induced cardiac pathology, mitochondrial mechanisms, and sex-specific differences. Utilizes heavy ion irradiation models (protons/oxygen ions) and investigates pharmacological interventions like POLY-MVA. Affiliations: University of Arkansas for Medical Sciences Division of Radiation Health Labs/Teams: Leads cardiovascular radiation injury research at UAMS Biomed II facility.

• Radiation Oncology
• Cardiovascular Toxicity
• Breast Cancer Research
• +۳ مورد دیگر

Anne Crijns is a Physician Scientist at the Faculty of Medical Sciences , University of Groningen. Specializing in radiation oncology and hematology, her research focuses on radiation-induced cardiac toxicity in breast cancer patients , with significant contributions to understanding long-term cardiovascular complications post-radiotherapy. Her work explores: Radiation dosimetry impacts on cardiac function Proton therapy for second primary cancer risk reduction AI applications in cardiac structure contouring Biological modeling of radiation-induced atherosclerosis Recent publications highlight collaborations with international experts across Radiology: Cardiothoracic Imaging , Radiotherapy and Oncology , and Clinical and Translational Radiation Oncology . Scientific recognition includes the 2020 Best of ASTRO Abstract Designation . Contact: a.p.g.crijns@umcg.nl

John Maduroمشاهده پروفایل

پزشک-پژوهشگر

• Oncology
• Radiation Therapy
• Breast Cancer
• +۳ مورد دیگر

Dr. John Maduro is a Radiation Oncologist at the Faculty of Medical Sciences/UMCG, University of Groningen, with a focus on breast cancer, pediatric oncology, and proton therapy. He contributes to national and international guidelines, including breast cancer radiotherapy protocols and pediatric radiation safety standards. Key Collaborations: Prinses Maxima Center for Pediatric Oncology, BOOG (Breast Cancer Research Group), NABON (Dutch Breast Cancer Registry) Research Themes: Proton therapy optimization, radiotherapy deintensification, late effects of radiation in pediatric patients, FLASH irradiation technology His work addresses UN Sustainable Development Goals related to health and well-being, with a particular emphasis on improving cancer survivorship quality and reducing treatment toxicity. Recent studies include developing prediction models for radiation-induced contrast enhancement and assessing nationwide trends in DCIS radiotherapy. He has received recognition, including the 2020 Best of ASTRO abstract designation. In 2022, he collaborated with IBA on FLASH therapy protocols for breast cancer, and in 2024, he contributed to the HARMONIC-RT European registry to evaluate long-term outcomes in pediatric radiotherapy. Scientific Awards : 2020 Best of ASTRO abstract

Soheil Hemmatiمشاهده پروفایل

استادیار

• Mathematical Optimization
• Healthcare Decision-Making
• Stochastic Optimization
• +۴ مورد دیگر

Soheil Hemmati is an Assistant Professor in the Department of Industrial & Systems Engineering at the University of Oklahoma. His research focuses on mathematical optimization models and their applications in healthcare decision-making, particularly in cancer care. He has expertise in stochastic optimization, integer programming, and bilevel optimization techniques for clinical applications. Ph.D. in Industrial and Systems Engineering from the University of Florida M.S. and B.S. in Industrial Engineering from Sharif University of Technology Dr. Hemmati's work spans cancer screening optimization, adaptive radiation therapy planning, and health policy modeling. He has developed novel approaches for organ-at-risk sparing, personalized screening schedules, and toxicity prediction frameworks using machine learning. His research intersects with cyber-physical systems through interdiction modeling applications. His recent publications in journals like American Journal of Obstetrics and Gynecology and Physics and Imaging in Radiation Oncology demonstrate his focus on clinical implementation challenges. He actively collaborates with cancer centers and has mentored students including Grant M. Benson (moving to UC Berkeley) and Kiana Amani. 2024 ASTRO Meeting Abstract Acceptance Dr. Hemmati leads a research group at the Carson Engineering Center, with lab collaborations spanning radiation oncology, biomedical engineering, and public health domains.

Alexandra Hotca-Choمشاهده پروفایل

استادیار

• Radiation Oncology
• Gastrointestinal Oncology
• Radiation Therapy Techniques
• +۳ مورد دیگر

Dr. Alexandra Hotca-Cho serves as an Assistant Professor in the Department of Radiation Oncology within the School of Medicine at the University of California, San Francisco (UCSF). Her clinical expertise centers on gastrointestinal cancers, where she employs advanced radiation modalities such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and respiratory gating to maximize tumor control while reducing adverse effects. Dr. Hotca-Cho is committed to patient advocacy and delivering compassionate, high-quality care to UCSF's diverse patient community. Her educational journey includes a Bachelor of Arts in Biology from Hunter College – CUNY (2014), followed by a Doctor of Medicine from Drexel University College of Medicine (2015-2019). She completed an Internal Medicine internship at Lenox Hill Hospital – Northwell Health (2019-2020) and a Radiation Oncology residency with a Chief Resident year at the Icahn School of Medicine at Mount Sinai (2020-2024). Dr. Hotca-Cho's research program is dedicated to improving cancer survivorship through two primary avenues: (1) developing preventive strategies to mitigate treatment-related toxicities, and (2) discovering predictive biomarkers that identify patients at risk for radiation-induced complications. Her scholarly work spans gastrointestinal oncology, precision radiation delivery, health equity, and quality-of-life outcomes. Recent publications demonstrate her leadership in hepatocellular carcinoma, esophageal cancer, and the application of proton therapy for recurrent malignancies. A review of her 15 most recent publications (2022-2024) highlights her focus on gastrointestinal malignancies and radiation toxicity management. Key themes include the safety of combined immunotherapy and radiation, predictive models for esophageal toxicity, and disparities in genomic testing and Medicaid coverage for cancer patients. Her work bridges clinical practice with translational research to enhance therapeutic precision. Her accolades include the Resident Clinical Excellence Award from Mount Sinai Hospital (2024) and the prestigious Luther W. Brady, MD Award from Drexel University College of Medicine (2019), recognizing her outstanding clinical performance and academic promise. While the source material does not specify current advisees or grant funding, Dr. Hotca-Cho's active research portfolio suggests ongoing mentorship of trainees and competitive research support. Similarly, no details about specific laboratories or research teams were provided, though her work likely involves multidisciplinary collaboration within UCSF's comprehensive cancer center.

• Radiation Oncology
• Prostate Cancer
• Rectal Cancer
• +۳ مورد دیگر

Alexander Valdman is an Associate Professor in Oncology at Karolinska Institutet and affiliated with the Department of Oncology-Pathology. He leads clinical research in radiotherapy for pelvic tumors, particularly prostate and rectal cancers, and contributes to national guidelines like the STRONG project for radiation therapy. His work focuses on optimizing treatment protocols, analyzing biomarkers, and improving patient outcomes through clinical trials such as PRORECT and CORRECT. Education: PhD in Oncology (2005) from Karolinska Institutet; Postdoc at Johns Hopkins University (2006-2007). Research interests include proton therapy , radiation toxicity , PSA response monitoring , and multidisciplinary treatment protocols . His recent publications emphasize comparative analyses of proton vs photon therapy , inflammatory biomarkers , and automated treatment planning for rectal and prostate cancers. Valdman actively collaborates on clinical trials and contributes to national radiation therapy data standardization projects. He is part of Åsa Carlsson Tedgren's Group at Karolinska University Hospital, focusing on clinical radiation therapy applications.